REGULATORY

Japan NIH to Have Drug Discovery Support Unit

December 9, 2014

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

A Japanese version of the US National Institutes of Health (NIH) will be comprised of six units including a unit to support drug discovery, the Cabinet Secretariat said on December 8. According to the Cabinet Secretariat, Makoto Suematsu of Keio…

To read the full story

Related LEXICON

Japan-Version NIH Initiative日本版NIH構想

June 30, 2014

REGULATORY

Japan Cabinet OKs Record Social Security Spending in FY2026 Budget, 105 Billion Yen in Drug Price Cuts
December 26, 2025
MHLW Names 77 Active Ingredients for OTC-Like Drug Charges
December 26, 2025
Japan Ministers Agree to Scrap “Spillover” Rule, Plan Wider CEA Price Cuts
December 25, 2025
Japan to Cut Drug Prices by 0.86% in FY2026; Central Govt Savings Seen at 105 Billion Yen
December 25, 2025
Japan Growth Strategy Council to Set Up Drug Discovery Working Group
December 25, 2025

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…

COMMENTARY

Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise

By Koji Shimomura

Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…